Beyond Air — raw details

Highlights

1 patent

About

Treatment Solutions for Respiratory Diseases

Beyond Air is harnessing nitric oxide's pulmonary, antimicrobial, anti-inflammatory, and immunomodulatory mechanisms of action to deliver global access to more treatment options from hospital to home.

Its revolutionary LungFit technology platform generates nitric oxide (NO) on-demand from ambient air and safely delivers it to patients to treat a variety of lung diseases. The LungFit PH is the first and only FDA approved system with patented Ionizer technology that generates nitric oxide using room air, enabling the delivery of unlimited, on-demand nitric oxide regardless of dose or flow.

Identity

Name	Beyond Air
Slug	beyond-air
Former names	Advanced Inhalation Therapies
Type / kind	startup
Crunchbase ID	ait
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ68zqEJDA

Status

Status	active
Status reason	Public on NASDAQ on Aug, 2015<br>
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Rehovot
HQ address	Eli Horovitz Street 12, Rehovot, Israel

Web & social

Website	https://www.beyondair.net/
Careers page	https://www.beyondair.net/careers
LinkedIn	https://www.linkedin.com/company/5256195
Twitter / X	https://twitter.com/BeyondAirInc

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals

Business models

B2B

Funding

Total raised	$69.5M
Current stage	Public
Market cap	$5.8M

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}